Loveli Design, LLC d/b/a Alice in Vapeland

Warning LetterOpen

John Flynn Loveli Design, LLC d/b/a Alice in Vapeland 5740 Osuna Rd NE Albuquerque , NM 87109 United States nicole@aliceinvapeland.com nicoleinvapeland@gmail.com brandon@aliceinvapeland.comFEI 3013961052Issued Feb 21, 2025Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3013961052.

Violations1

Issue DateFeb 21, 2025

Product TypeTobacco

StatusOpen

Letter Details

Firm: Loveli Design, LLC d/b/a Alice in Vapeland
Location: John Flynn Loveli Design, LLC d/b/a Alice in Vapeland 5740 Osuna Rd NE Albuquerque , NM 87109 United States nicole@aliceinvapeland.com nicoleinvapeland@gmail.com brandon@aliceinvapeland.com
FEI Number: 3013961052
Country: United States
Issue Date: February 21, 2025
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Loveli Design, LLC d/b/a Alice in Vapeland was cited for manufacturing and selling e-liquid tobacco products through their website (aliceextracts.com) without required premarket authorization. The company failed to comply with FDA regulations governing tobacco products under the Federal Food, Drug, and Cosmetic Act, including products containing nicotine from any source as defined under the 2022 legislation expanding FDA jurisdiction. The warning identified the products as unapproved "new tobacco products" that must obtain premarket authorization orders before legally marketing in the United States.

Loveli Design, LLC d/b/a Alice in Vapeland FDA Warning Letter, February 21, 2025